Nektar Therapeutics financial data

Symbol
NKTR on Nasdaq
Location
455 Mission Bay Boulevard South, San Francisco, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 355 % -43.7%
Quick Ratio 12.9 % -61.9%
Debt-to-equity 985 % +352%
Return On Equity -493 % -246%
Return On Assets -45.5 % -1.41%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19M shares -89.7%
Common Stock, Shares, Outstanding 12.5M shares -93.2%
Entity Public Float 226M USD +107%
Common Stock, Value, Issued 1K USD -94.7%
Weighted Average Number of Shares Outstanding, Basic 14.1M shares +1.19%
Weighted Average Number of Shares Outstanding, Diluted 14.1M shares +1.19%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 74.9M USD -19.6%
Research and Development Expense 124M USD +11.7%
General and Administrative Expense 77.5M USD -2.04%
Costs and Expenses 176M USD -31.6%
Operating Income (Loss) -101M USD +38.4%
Nonoperating Income (Expense) -15M USD -10.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -119M USD +56.9%
Income Tax Expense (Benefit) -386K USD -389%
Net Income (Loss) Attributable to Parent -122M USD +31%
Earnings Per Share, Basic 0 USD/shares +21.5%
Earnings Per Share, Diluted 0 USD/shares +21.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 43M USD +53.9%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Inventory, Net 0 USD -100%
Other Assets, Current 10.7M USD +28.6%
Assets, Current 187M USD -36.8%
Property, Plant and Equipment, Net 2.99M USD -80.3%
Operating Lease, Right-of-Use Asset 7.59M USD -17.9%
Goodwill 0 USD -100%
Other Assets, Noncurrent 5.02M USD +16.5%
Assets 208M USD -39.6%
Accounts Payable, Current 14.3M USD +121%
Employee-related Liabilities, Current 6.55M USD -24.9%
Accrued Liabilities, Current 35.1M USD +18.9%
Liabilities, Current 71.4M USD +24.5%
Operating Lease, Liability, Noncurrent 74.1M USD -18.3%
Other Liabilities, Noncurrent 5.64M USD -30%
Liabilities 232M USD -12.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -14K USD +97.2%
Retained Earnings (Accumulated Deficit) -3.69B USD -3.43%
Stockholders' Equity Attributable to Parent -24.2M USD -130%
Liabilities and Equity 208M USD -39.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -49.1M USD -2.43%
Net Cash Provided by (Used in) Financing Activities 42M USD
Net Cash Provided by (Used in) Investing Activities 43.7M USD +127%
Common Stock, Shares Authorized 390M shares +30%
Common Stock, Shares, Issued 13M shares -93.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.36M USD -140%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 43M USD +53.9%
Deferred Tax Assets, Valuation Allowance 859M USD +0.53%
Deferred Tax Assets, Gross 862M USD +0.45%
Operating Lease, Liability 103M USD -12.9%
Payments to Acquire Property, Plant, and Equipment 157K USD -63.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -122M USD +28.8%
Lessee, Operating Lease, Liability, to be Paid 119M USD -15.4%
Operating Lease, Liability, Current 22M USD +3.16%
Lessee, Operating Lease, Liability, to be Paid, Year Two 23M USD +3.16%
Lessee, Operating Lease, Liability, to be Paid, Year One 20.5M USD +3.17%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) -38K USD +97.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 16.3M USD -28.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 23.7M USD +3.15%
Deferred Tax Assets, Operating Loss Carryforwards 588M USD +2.23%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 136M USD +7.25%
Lessee, Operating Lease, Liability, to be Paid, Year Four 24.4M USD +3.15%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 3.38M USD -17.4%
Share-based Payment Arrangement, Expense 17.6M USD -34.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%